IFF stock plunges nearly 20% as inventory costs fuel big miss, sales outlook cut
By Wallace Witkowski
Higher inventory costs nearly double to $180 million
International Flavors & Fragrances Inc. shares fell off a cliff in the extended session Monday after the company said higher inventory costs nearly doubled, and cut its sales forecast for the year.
IFF (IFF) shares dropped 19% after hours, following a 0.2% decline in the regular session to close at $80.34, as the S&P 500 index SPX finished the day up 0.9%. IFF shares closed Monday down 23.4% for the year, while the S&P 500 has gained 17.7%.
The company reported second-quarter net income of $27 million, or 11 cents a share, compared with $107 million, or 43 cents a share, in the year-ago period.
Adjusted earnings, which exclude stock-based compensation expenses and other items, were 34 cents a share, compared with 93 cents a share in the year-ago period. Analysts surveyed by FactSet had forecast earnings of $1.10 a share.
Revenue declined to $2.93 billion from $3.31 billion in the year-ago quarter, while analysts had estimated $3.07 billion.
Sales in food products, IFF's largest segment, fell 14% to $1.56 billion, while sales in the health and biosciences segment dropped 21.5% to $522 million. Analysts had forecast $1.68 billion for foods, and $550.5 million in health and biosciences sales.
"The continued customer destocking and volume pressures in the second quarter reflect the broader macroeconomic challenges facing our industry, and for IFF," said Frank Clyburn, IFF's chief executive, in a statement.
Clyburn added that the pressures are "largely isolated" in its functional ingredients business within its food, or "Nourish," segment, which covers food ingredients, flavors and designs.
IFF said it now expects full-year sales to be between $11.3 billion and $11.6 billion, down from a previous estimate of about $12.3 billion, on the "expectation that volumes in the second half of 2023 will not recover as previously expected, driven particularly by continued customer destocking."
Analysts, on average, forecast $12.16 billion.
The company said it expects "higher manufacturing absorption" costs for the year of about $180 million, up from its previous estimate of about $100 million.
-Wallace Witkowski
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-08-23 0825ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations